Skip to content

Clinical-radiological outcome of trochleoplasty for patellofemoral instability and trochleadysplasia - a retrospective case series

Clinical-radiological outcome of trochleoplasty for patellofemoral instability and trochleadysplasia - a retrospective case series

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023634
Enrollment
40
Registered
2021-03-01
Start date
2020-07-29
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathological dislocation and subluxation of a joint, not elsewhere classified : Lower leg [fibula, tibia, knee joint]. M22.0 M24.36 Q74.1

Interventions

Group 1: Study participants who have undergone trochleoplasty with dynamic MPFL reconstruction at the MHH Orthopaedic Clinic at Diakovere Annastift will be invited for a clinical follow-up. As part of

Sponsors

Medizinische Hochschule Hannover
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with trochleoplasty MPFL reconstruction incl. other concomitant procedures. - Age from 15 years

Exclusion criteria

Exclusion criteria: - Known hereditary connective tissue diseases (e.g. Ehlers-Danlos syndrome) - Known neurogenic diseases - Significant other known musculoskeletal diseases

Design outcomes

Primary

MeasureTime frame
The primary endpoint consists of completion of scores (Banff II score, Kujala score, and Norwich patella score, VAS pain scale) and an assessment of the patient's surgical outcome by school grades, whether he or she would have the procedure performed again, and a clinical and radiologic examination.

Secondary

MeasureTime frame
The secondary endpoint is the evaluation of the available radiographs and MRI scans.

Countries

Germany

Contacts

Public ContactYvonne Noll

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift, Leitung Klinisches Studienmanagement

yvonne.noll@diakovere.de0511-5354-649

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026